Manufacturer VerifiedUnited States

GE HealthCare Technologies Inc.

GE HealthCare

GE HealthCare Technologies Inc. is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, spun off from General Electric as an independent company in 2023, with its operational heritage dating back over a century. Based in Chicago, Illinois, United States, the company delivers integrated solutions across four core segments — Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics — encompassing magnetic resonance imaging (MRI) systems, computed tomography (CT) scanners, molecular imaging and X-ray systems, handheld and console ultrasound platforms, patient monitoring and anesthesia delivery systems, maternal-infant care devices, and iodinated contrast media and radiopharmaceutical agents. With annual revenue of US$20.625 billion in 2025, GE HealthCare operates 30+ major manufacturing and R&D facilities globally, employing approximately 54,000 employees serving customers across 160+ countries. As a newly independent entity named to the Fortune World's Most Admired Companies 2025, GE HealthCare is accelerating its precision care strategy through AI-enabled imaging, theranostics, and digital health platforms.

Strengths: Unmatched installed base with over 5 million imaging systems deployed globally, creating a massive recurring service and consumables revenue stream. AI leadership in medical imaging with over 80 FDA-cleared AI-enabled devices, the most of any medical technology company. Pharmaceutical Diagnostics moat as one of the world's largest producers of iodinated contrast media with significant manufacturing barriers to entry. Strong order backlog with 1.07x book-to-bill ratio in 2025, indicating sustained demand momentum. Newfound agility as an independent company with streamlined decision-making and focused capital allocation.
Weaknesses: Slower growth profile relative to pure-play medtech peers, with organic revenue growth of 3.5% in 2025 trailing the broader medical device sector. China market exposure to geopolitical tensions and anticorruption campaigns that have depressed hospital capital spending. Legacy cost structure inherited from GE that requires continued restructuring to achieve competitive margins.

Business Nature

GE HealthCare Technologies Inc. operates as an independent global medical technology, pharmaceutical diagnostics, and digital solutions company. Spun off from General Electric in 2023, the company maintains a heavy manufacturing and R&D footprint with over 30 major facilities worldwide, producing complex capital equipment including MRI magnets, CT detectors, ultrasound transducers, and contrast media agents. The business model combines high-margin equipment sales with multi-year service contracts and recurring consumables revenue, with approximately 45% of total revenue derived from recurring service and pharmaceutical diagnostic streams. The company is guided by a precision care strategy that integrates AI-powered imaging devices, digital health platforms, and disease-specific solutions.

Core Business Areas

Imaging – Advanced Diagnostic Imaging Systems • SIGNA MRI systems from 0.23T to 7.0T with AIR Recon DL deep learning reconstruction • Revolution CT scanners with deep silicon detector technology and cardiac imaging capabilities • Omni Legend PET/CT and StarGuide SPECT/CT for molecular imaging and theranostics • Definium and AMX digital X-ray systems for radiography and fluoroscopy • Senographe Pristina mammography platforms with contrast-enhanced biopsy capabilities Ultrasound – Point-of-Care & Console Ultrasound • LOGIQ, Vivid, and Voluson ultrasound platforms for general imaging, cardiology, and women's health • Venue Family point-of-care ultrasound with AI-guided acquisition tools • Vscan Air handheld wireless dual-probe ultrasound system Patient Care Solutions – Monitoring & Anesthesia • CARESCAPE patient monitoring ecosystem for acute and critical care • Aisys and Carestation anesthesia delivery systems • Giraffe and Panda incubators and warmers for neonatal and maternal care Pharmaceutical Diagnostics – Contrast Media & Radiopharmaceuticals • Omnipaque and Visipaque iodinated contrast media for CT and interventional imaging • Clariscan MRI contrast agent • DaTscan and Cerianna radiopharmaceuticals for neurology and oncology imaging

Industry Rankings

6Top 10 Advanced Medical Equipment Companies

Brand

6Top 10 Advanced Medical Equipment Manufacturers & Suppliers

Mfr

Corporate Report

GE HealthCare Technologies Inc. is a global leader in medical imaging, ultrasound, and pharmaceutical diagnostics, headquartered in Chicago, Illinois. Spun off from General Electric in 2023, the company has established itself as an independent force in medtech with US$20.625 billion in 2025 revenue, 54,000 employees, and operations spanning 160+ countries.

Core Business

GE HealthCare operates through four reportable segments — Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics (PDx). The Imaging segment, accounting for the largest share of revenue, encompasses MRI, CT, molecular imaging, X-ray, and mammography systems with a significant installed base exceeding 5 million units globally. The PDx segment represents a unique competitive advantage as one of the world's few large-scale manufacturers of iodinated contrast media, with a dedicated manufacturing campus in Cork, Ireland recently expanded with a US$138 million investment. The company's AI-enabled portfolio includes over 80 FDA-cleared AI devices, more than any other medical technology company.

Global Presence

The company maintains 30+ major manufacturing and R&D facilities across the United States, Europe, and Asia, with flagship sites in Waukesha (Wisconsin), Cork (Ireland), Hino (Japan), and Beijing (China). With approximately 54,000 employees worldwide, the company serves customers in 160+ countries. Key growth markets include the United States (largest market), EMEA, and China, with emerging market expansion focused on Southeast Asia, India, and Latin America. The company achieved a 1.07x book-to-bill ratio in 2025, indicating strong demand momentum across all segments.

Key Strengths

GE HealthCare's competitive advantages stem from its massive installed base generating recurring service and consumables revenue, leadership in AI-enabled medical imaging with the most FDA-cleared AI devices in the industry, and a unique pharmaceutical diagnostics franchise with high barriers to entry. The company's spin-off from GE has unlocked strategic agility, enabling more focused capital allocation and faster decision-making. Named to Fortune's World's Most Admired Companies 2025, GE HealthCare is building momentum in precision care through theranostics and digital health platform innovation.

VerityRank Score

VerityRank Score of 89/100

VerityRank Score

89/ 100

Based on market presence, financial scale, operational capacity, and brand strength.

Quick Facts

Headquarters

Chicago, Illinois, United States

Founded

2023

Employees

54,000

Factories

30+ major manufacturing and R&D facilities worldwide

Listing

Nasdaq: GEHC

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website Nasdaq: GEHC , Data Sources & Methodology

GE HealthCare Official Website
GE HealthCare - Wikipedia
GE HealthCare Investor Relations
GE HealthCare Revenue - Macrotrends
GE HealthCare 2025 Full Year Results

Back to Rankings